Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 1
2012 2
2013 1
2014 3
2015 2
2016 2
2017 5
2018 10
2019 8
2020 9
2021 13
2022 10
2023 8
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens.
Saad E, Gebrael G, Semaan K, Eid M, Saliby RM, Labaki C, Sayegh N, Wells JC, Takemura K, Ernst MS, Lemelin A, Basappa NS, Wood LA, Powles T, Ernst DS, Lalani AA, Agarwal N, Xie W, Heng DYC, Choueiri TK. Saad E, et al. Among authors: takemura k. Oncologist. 2024 Apr 17:oyae072. doi: 10.1093/oncolo/oyae072. Online ahead of print. Oncologist. 2024. PMID: 38630540 Free article.
Reply to Yudai Ishiyama and Fumihiko Urabe's Letter to the Editor re: Kosuke Takemura, Audreylie Lemelin, Matthew S. Ernst, et al. Outcomes of Patients with Brain Metastases from Renal Cell Carcinoma Receiving First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.01.006.
Takemura K, Yuasa T, Choueiri TK, Heng DYC. Takemura K, et al. Eur Urol. 2024 Mar 25:S0302-2838(24)02237-1. doi: 10.1016/j.eururo.2024.03.016. Online ahead of print. Eur Urol. 2024. PMID: 38531704 No abstract available.
Anger and disgust shape judgments of social sanctions across cultures, especially in high individual autonomy societies.
Andersson PA, Vartanova I, Västfjäll D, Tinghög G, Strimling P, Wu J, Hazin I, Akotia CS, Aldashev A, Andrighetto G, Anum A, Arikan G, Bagherian F, Barrera D, Basnight-Brown D, Batkeyev B, Berezina E, Björnstjerna M, Boski P, Bovina I, Huyen BTT, Čekrlija Đ, Choi HS, Contreras-Ibáñez CC, Costa-Lopes R, de Barra M, de Zoysa P, Dorrough AR, Dvoryanchikov N, Engelmann JB, Euh H, Fang X, Fiedler S, Foster-Gimbel OA, Fülöp M, Gardarsdottir RB, Gill CMHD, Glöckner A, Graf S, Grigoryan A, Gritskov V, Growiec K, Halama P, Hartanto A, Hopthrow T, Hřebíčková M, Iliško D, Imada H, Kapoor H, Kawakami K, Khachatryan N, Kharchenko N, Kiyonari T, Kohút M, Leslie LM, Li Y, Li NP, Li Z, Liik K, Maitner AT, Manhique B, Manley H, Medhioub I, Mentser S, Nejat P, Nipassa O, Nussinson R, Onyedire NG, Onyishi IE, Panagiotopoulou P, Perez-Floriano LR, Persson M, Pirttilä-Backman AM, Pogosyan M, Raver J, Rodrigues RB, Romanò S, Romero PP, Sakki I, San Martin A, Sherbaji S, Shimizu H, Simpson B, Szabo E, Takemura K, Teixeira MLM, Thanomkul N, Tiliouine H, Travaglino GA, Tsirbas Y, Widodo S, Zein R, Zirganou-Kazolea L, Eriksson K. Andersson PA, et al. Among authors: takemura k. Sci Rep. 2024 Mar 7;14(1):5591. doi: 10.1038/s41598-024-55815-x. Sci Rep. 2024. PMID: 38454068 Free PMC article.
Outcomes of Patients with Brain Metastases from Renal Cell Carcinoma Receiving First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Takemura K, Lemelin A, Ernst MS, Wells JC, Saliby RM, El Zarif T, Labaki C, Basappa NS, Szabados B, Powles T, Davis ID, Wood LA, Lalani AA, McKay RR, Lee JL, Meza L, Pal SK, Donskov F, Yuasa T, Beuselinck B, Gebrael G, Agarwal N, Choueiri TK, Heng DYC. Takemura K, et al. Eur Urol. 2024 Jan 29:S0302-2838(24)00005-8. doi: 10.1016/j.eururo.2024.01.006. Online ahead of print. Eur Urol. 2024. PMID: 38290965 Free article.
Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Takemura K, Ernst MS, Navani V, Wells JC, Bakouny Z, Donskov F, Basappa NS, Wood LA, Meza L, Pal SK, Szabados B, Powles T, Beuselinck B, McKay RR, Lee JL, Ernst DS, Kapoor A, Yuasa T, Choueiri TK, Heng DYC. Takemura K, et al. Eur Urol Oncol. 2023 Oct 30:S2588-9311(23)00217-1. doi: 10.1016/j.euo.2023.10.002. Online ahead of print. Eur Urol Oncol. 2023. PMID: 37914579
Prognostic Models in Metastatic Renal Cell Carcinoma.
Lemelin A, Takemura K, Heng DYC, Ernst MS. Lemelin A, et al. Among authors: takemura k. Hematol Oncol Clin North Am. 2023 Oct;37(5):925-935. doi: 10.1016/j.hoc.2023.04.016. Epub 2023 Jun 1. Hematol Oncol Clin North Am. 2023. PMID: 37270385 Review.
65 results